DermaVeen Sensitive Sun Ultralite SPF 50
SPF 50, broad spectrum, lotion. AUST L 523734, from iNova Pharmaceuticals (Australia) Pty Ltd.
Keep using sunscreen. The TGA says its benefits far outweigh any risks, and nothing here says a product is unsafe: the limits are proposals.
Active ingredients
| Ingredient | On the ARTG as | Amount | % |
|---|---|---|---|
| Octocrylene | octocrylene | 50 mg/g | 5% |
| Octisalate | octyl salicylate | 45 mg/g | 4.5% |
| Avobenzone | butyl methoxydibenzoylmethane | 30 mg/g | 3% |
| Ethylhexyl triazone | ethylhexyl triazone | 30 mg/g | 3% |
Percent by weight: the ARTG gives each active in mg per gram, and 10 mg/g is 1%.
Against the TGA’s proposed limits
This sunscreen lists none of the three filters under review (homosalate, oxybenzone and 4-MBC), so none of the proposed limits would apply to it.
Where this comes from
Everything above is from this product’s entry on the Australian Register of Therapeutic Goods: ARTG 523734, DermaVeen Sensitive Sun Ultralite SPF 50. We read its public summary on 21 October 2026; the entry dates from 23 February 2026. The name on the shelf can differ from the register’s. If the label shows a different AUST L number, it’s a different formula. Spotted a mistake? Email hello@sunscreenfilters.com.
Worried about an ingredient, or choosing for a baby or someone with sensitive skin? Talk to your doctor or pharmacist.
More from DermaVeen
- Dermaveen Sensitive Sun Invisible Fluid SPF 50+ Homosalate 10%, Octocrylene 8%, Octisalate 5%, Avobenzone 4% Homosalate 10%, above all three TGA proposed limits
- DermaVeen Sensitive Sun SPF 50+ 4-MBC 4%, Avobenzone 4%, Octocrylene 4%, Ethylhexyl triazone 3% 4-MBC 4%, above both TGA proposed limits
- DermaVeen Ultra Light Day Lotion SPF50+ Homosalate 10%, Octisalate 5%, Bemotrizinol 3%, Avobenzone 3%, Ethylhexyl triazone 2%, Ensulizole 1.5% Homosalate 10%, above all three TGA proposed limits